Skip to Content

Manzo Pharmaceuticals Inc MNZO

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MNZO is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$1.64
Uncertainty
Extreme
1-Star Price
$6.76
5-Star Price
Economic Moat
Ktdytl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MNZO is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$5.25
Volume/Avg
3,000 / 3,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Manzo Pharmaceuticals Inc formerly known as Fortune Oil & Gas Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The company also develops its lactose intolerance product, in which it holds an exclusive patent license. Its primary products are dietary supplements, probiotics and natural remedies. In addition tit also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Geographically, operation of the group is functioned through United States.
Sector
Financial Services
Industry
Shell Companies
Stock Style Box
Total Number of Employees

Valuation

Metric
MNZO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MNZO
Quick Ratio
0.17
Current Ratio
0.20
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
MNZO
Return on Assets (Normalized)
292.84%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Shell Companies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Petro USA Inc
PBAJ
Lblbtf$1.0 Bil
Churchill Capital Corp VII Ordinary Shares - Class A
CVII
Tpyhjqv$987.1 Mil
Ares Acquisition Corp II Ordinary Shares - Class A
AACT
Mpqnfy$668.8 Mil
Admiral Acquisition Ltd
ADMNF
Gbwqvd$535.7 Mil
Agriculture & Natural Solutions Acquisition Corp Class A
ANSC
Zydszdj$443.3 Mil
Nabors Energy Transition Corp II Ordinary Shares - Class A
NETD
Xyqpclt$402.6 Mil
World Financial Holding Group
WFHG
Bddxmd$381.1 Mil
Churchill Capital Corp IX Ordinary Shares - Class A
CCIX
Xxtknpm$367.4 Mil
Rigel Resource Acquisition Corp Ordinary Shares - Class A
RRAC
Fkkkgkf$364.3 Mil
GP-Act III Acquisition Corp Class A Ordinary Shares
GPAT
Jvxygv$359.7 Mil

Sponsor Center